Diaceutics (FRA:7DC) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 05, 2026)


FRA:7DC Diaceutics PLC FRA:7DC
91 GF Score
Price €1.64
GF Value €2.15
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Diaceutics Float Percentage Of Total Shares Outstanding?

Diaceutics FRA:7DC -0.61% 91 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 05, 2026. GuruFocus rates FRA:7DC with a GF Score™ of 91/100 and a GF Value™ of €2.15 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Diaceutics's float shares is 0.00 Mil. Diaceutics's total shares outstanding is 84.63 Mil. Diaceutics's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Diaceutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Diaceutics's Institutional Ownership is 32.31%.

FRA:7DC
91GF Score
Diaceutics PLC FRA:7DC
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diaceutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Diaceutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/84.63
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Diaceutics (FRA:7DC) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 05, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Diaceutics and its competitors.
Is Diaceutics' Float Percentage Of Total Shares Outstanding too high?
Diaceutics' current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Diaceutics has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Diaceutics' Float Percentage Of Total Shares Outstanding compare to VEEV and BTSG?
Diaceutics' Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Healthcare Providers & Services company?
A good Float Percentage Of Total Shares Outstanding depends on the Healthcare Providers & Services industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Diaceutics and its competitors. Diaceutics's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diaceutics stock overvalued right now?
Based on GuruFocus' analysis, Diaceutics (FRA:7DC) is currently considered Modestly Undervalued. The stock's GF Value™ is €2.15, compared to a current price of €1.64 — trading 23.7% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Diaceutics' overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Diaceutics (FRA:7DC), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diaceutics (FRA:7DC) Overvalued in 2026?

Based on GuruFocus' analysis, Diaceutics stock appears to be undervalued. The current stock price of €1.64 is trading 23.7% below its estimated GF Value™ of €2.15. GuruFocus considers Diaceutics to be Modestly Undervalued.

Key valuation signals for FRA:7DC:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: €2.15 vs. price of €1.64 (23.7% below fair value)
  • GF Score™: 91/100 with 1 warning sign

No single metric tells the full story. See the FRA:7DC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diaceutics Business Description

Other Exchanges DIUXF:USADXRX:UK
Address Dataworks at Kings Hall Health & Wellbeing Park, First Floor, Building Two, County Antrim, Belfast, GBR, BT9 6GW
Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides integrated commercialization solutions that help biopharma companies maximize patient access, accelerate uptake, and improve the lifetime value of their therapies. The group's services span the full commercial lifecycle, from pre-launch ideas through to mature brand optimization, delivered through an integrated combination of data, technology, and expertise. Its DXRX Data Solutions include DXRX Signal, DXRX Physician Segmentation, DXRX Lab Segmentation, and DXRX Disease Testing Rate Tracker. Geographical market by customer location in the UK, North America, Europe, Asia, and the rest of the world.
91GF Score

Get the complete analysis for FRA:7DC

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.64
Price
€2.15
GF Value